Amphastar Sanctioned For Veiling Docs Over Blood Thinner IP

Law360, Los Angeles (December 5, 2013, 5:32 PM EST) -- A Massachusetts federal judge on Thursday hit Amphastar Pharmaceuticals Inc. with sanctions for disobeying discovery requests in Momenta Pharmaceuticals Inc.’s patent suit against Amphastar over production of generic versions of the blood thinner Lovenox, finding that Amphastar’s refusal to turn over documents violated court orders.

U.S. Magistrate Judge Robert B. Collings ruled that Amphastar’s behavior was “quite serious and possibly contumacious” in not handing over unredacted versions of its Abbreviated New Drug Application and other correspondence with the U.S. Food and Drug Administration. But even though...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.